3CIBISⅡInvestigators and Committees.The cardiac insufficiencybisoprolol studyⅡ(CIBIS-Ⅱ)a randomised trail[].The Lancet.1999
4The consensus trial study group.Effect of eanalapril on mortality in se-vere congestive heart failure:results of the cooperative North Scandi-navian Enalapril Survival Study[].The New England Journal of Medicine.1987
5Cicoira M,Zanolla L,Rossi A,et al.Long-term,dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure[].Journal of the American College of Cardiology.2002
6Packer M.Therapeutic options in the management of chronic heart fail-ure[].Circulation.1989
7Pitt B,Remme W,Zannad F,et al.Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction[].The New England Journal of Medicine.2003
8Packer M,Bristow MR,Cohn JN,et al.The effect of carvedilol on mor-bidity and mortality in patietns with chronic heart failure[].The New England Journal of Medicine.1996
9Cucchini F.Chronic treatment of dilated cardiomyopathy by beta-block-ing agents:clinical and hemodynacic follow-up[].Eng Aabstr.1998
10MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL randomised intervention trial in congestive heart failure(MERIT-HF)[].The Lancet.1999
